# Observational uterine cancer studies recruiting: 21 (2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 21 trials that are observational for uterine cancer that are recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Recruiting observational uterine cancer studies: 21 rows for $5, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 1 row a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email.

Buy: https://specstream.ai/data/clinical-trials/recruiting/observational/uterine-neoplasms

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 21
- Recruiting or not yet: 21
- Read on: November 19, 2026

## Trials

The 21 newest of 21, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| October 20, 2026 | NCT07883798 | Radiotherapy for Gynecologic Cancer With Up to 10 Active Metastatic Lesions | Affidea Nu-med Center of Oncological DIagnostics and Therapy | Observational | Recruiting | Cervical Cancer, Gynecologic Cancer, Endometrial Cancer, Uterine Cancer, Uterine Sarcoma, Ovarian Cancer, Fallopian... | 500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07883798) |
| September 9, 2026 | NCT07810920 | Artificial Intelligence Into Ultrasound Diagnostics in Reproductive Medicine | Semmelweis University | Observational | Recruiting | Endometriosis, Adenomyosis of Uterus, Leiomyoma (Uterine Fibroids), Uterine Neoplasms, Congenital Abnormalities... | 1,600 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07810920) |
| June 24, 2026 | NCT07667192 | Reirradiation and Total Ablative Strategies for Recurrent Gynecologic Cancer | Affidea Nu-med Center of Oncological DIagnostics and Therapy | Observational | Recruiting | Recurrent Gynecologic Cancer, Recurrent Uterine Cancer, Recurrent Cervical Cancer, Recurrent Vaginal Cancer, Recurrent... | 500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07667192) |
| June 12, 2026 | NCT07645716 | Evaluation of Interactions and Group Processes in Multidisciplinary Tumor Boards in Gynecologic Oncology | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | Observational | Not yet recruiting | Ovarian Neoplasms, Uterine Neoplasms | 400 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07645716) |
| May 12, 2026 | NCT07581288 | Measurement of Urinary Hormones in Patients With Abnormal Uterine Bleeding to Study Uterine Cancer Progression | University of British Columbia | Observational | Not yet recruiting | Uterine Bleeding, Uterine Cancer, Uterine Neoplasms, Endometrial Cancer, Endometrial Hyperplasia, Endometrial... | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07581288) |
| February 2, 2026 | NCT07382505 | Prospective Cohort Study of Minimal Residual Disease(MRD) Testing for Early Recurrence Detection in Endometrial and Cervical Cancer | Asan Medical Center | Observational | Not yet recruiting | Uterine Neoplasms, Cervical Cancer | 600 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07382505) |
| January 5, 2026 | NCT07318051 | Sample Collection for Ongoing Research and Product Evaluation Study | Natera, Inc. | Observational | Recruiting | Breast Cancer, Lung Cancer, Muscle Invasive Bladder Cancer, Rectal Cancer, Pancreatic Cancer, Ovarian Cancer... | 9,600 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07318051) |
| December 4, 2025 | NCT07264660 | Diagnostic Value of Transcervical True-Cut Biopsy in Uterine Masses | Assiut University | Observational | Not yet recruiting | Uterine Tumor | 42 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07264660) |
| May 1, 2025 | NCT06953076 | Ultrasound Transformation of Myomas During Relugolix-Estradiol-Norethisterone Treatment: The MySaturn Study | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | Observational | Recruiting | Uterine Bleeding, Uterine Leiomyomas, Uterine Hemorrhage, Uterine Neoplasms | 111 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06953076) |
| January 29, 2025 | NCT06799624 | Prognostic Role of molEcular classiFication in Fertility-sparing treAtment of Endometrial canCEr | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | Observational | Not yet recruiting | Uterine Cancer | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06799624) |
| January 14, 2025 | NCT06774482 | Evaluation of Toxicity and Outcomes of Different Therapeutic Strategies in Patients With Uterine Neoplasms | IRCCS Azienda Ospedaliero-Universitaria di Bologna | Observational | Recruiting | Uterine Neoplasms | 3,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06774482) |
| July 30, 2024 | NCT06527157 | Investigations of Reproductive Cancers in Women | PinkDx, Inc. | Observational | Recruiting | Uterine Cancer | 4,500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06527157) |
| June 6, 2024 | NCT06447064 | Cancer Loyalty Card Study 2 (CLOCS-2) | Imperial College London | Observational | Recruiting | Pancreatic Cancer, Colon Cancer, Oesophageal Cancer, Stomach Cancer, Liver Cancer, Bladder Cancer, Uterine Cancer... | 2,900 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06447064) |
| May 1, 2024 | NCT06392997 | Evaluation of Salivary RNA in Subjects Scheduled for Surgery for a Gynecologic Pathology | ZIWIG | Observational | Recruiting | Gynecologic Disease, Gynecologic Cancer, Endometriosis, Ovarian Cancer, Cyst Ovary, Fibroid, Cervical Cancer, Uterine... | 2,500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06392997) |
| January 12, 2024 | NCT06203106 | NYSCF Scientific Discovery Biobank | New York Stem Cell Foundation Research Institute | Observational | Recruiting | ALS, Amyotrophic Lateral Sclerosis, Alzheimer Disease, Alzheimer Disease, Early Onset, Alzheimer Disease, Late Onset... | 10,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06203106) |
| September 6, 2023 | NCT06024109 | Performance of SYMMCORA® vs. V-Loc® Suture Material in Patients Undergoing Laparoscopic Total Hysterectomy | Aesculap AG | Observational | Recruiting | Abnormal Uterine Bleeding, Endometriosis, Uterine Prolapse, Uterine Cancer, Ovarian Cancer, Fallopian Tube Cancer... | 132 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06024109) |
| August 4, 2023 | NCT05977621 | Trans-Rectal Ultrasound of the Female Pelvis for Real-Time MRI-US Fusion Based Needle Tracking | Duke University | Observational | Recruiting | Uterine Cancer | 17 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05977621) |
| February 16, 2022 | NCT05242861 | Retrospective Study of Brachytherapy | Zhejiang Cancer Hospital | Observational | Recruiting | Brachytherapy, Uterine Cervical Neoplasms, Uterine Neoplasms, Vulvar Cancer, Vaginal Cancer, Ovarian Neoplasms... | 300 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05242861) |
| September 20, 2021 | NCT05049538 | Determine the Utility of Liquid Biopsies and Tumor Molecular Profiling in Predicting Recurrence in Endometrial Cancers | M.D. Anderson Cancer Center | Observational | Recruiting | Endometrial Clear Cell Adenocarcinoma, Endometrial Dedifferentiated Carcinoma, Endometrial Mucinous Adenocarcinoma... | 1,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05049538) |
| October 11, 2018 | NCT03702309 | Liquid Biopsy Evaluation and Repository Development at Princess Margaret | University Health Network, Toronto | Observational | Recruiting | Cancer, Breast Cancer, Lung Cancer, Colon Cancer, Ovarian Cancer, Melanoma, Lymphoma, Leukemia, Mutation, Lynch... | 2,500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03702309) |
| August 10, 2018 | NCT03624712 | Analysis and Optimization of Predictive and Therapeutic Models in Uterine Neoplasms | University Hospital Tuebingen | Observational | Recruiting | Uterine Neoplasms | 580 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03624712) |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 2 |
| Affidea Nu-med Center of Oncological DIagnostics and Therapy | 2 |
| ZIWIG | 1 |
| M.D. Anderson Cancer Center | 1 |
| Asan Medical Center | 1 |
| [Natera, Inc.](https://specstream.ai/data/clinical-trials/company/natera-inc) | 1 |
| Imperial College London | 1 |
| [Aesculap AG](https://specstream.ai/data/clinical-trials/company/aesculap-ag) | 1 |
| University Health Network, Toronto | 1 |
| Assiut University | 1 |
| Semmelweis University | 1 |
| Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 1 |
| University of British Columbia | 1 |
| Duke University | 1 |
| Zhejiang Cancer Hospital | 1 |
| University Hospital Tuebingen | 1 |
| PinkDx, Inc. | 1 |
| New York Stem Cell Foundation Research Institute | 1 |
| IRCCS Azienda Ospedaliero-Universitaria di Bologna | 1 |

## By country

| Country | Trials |
| --- | --- |
| United States | 5 |
| Italy | 4 |
| Poland | 2 |
| Germany | 2 |
| Canada | 2 |
| France | 1 |
| South Korea | 1 |
| United Kingdom | 1 |
| Spain | 1 |
| Hungary | 1 |
| China | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Tenant and eviction law firms in the United States](https://specstream.ai/data/businesses/tenant-and-eviction-law-firms/united-states)
- [Orthopedic surgery practices in the United States](https://specstream.ai/data/businesses/orthopedic-surgery-practices/united-states)
- [Gerontology practices in the United States](https://specstream.ai/data/businesses/gerontology-practices/united-states)
- [Ceiling and roofing repair and companies in the United States](https://specstream.ai/data/businesses/ceiling-and-roofing-repair-and-companies/united-states)
- [Video production companies in the United States](https://specstream.ai/data/businesses/video-production-companies/united-states)
- [Playground equipment suppliers in the United States](https://specstream.ai/data/businesses/playground-equipment-suppliers/united-states)
